StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Jiangsu Hengrui Medicine Co., Ltd.
Shanghai Stock Exchange:600276.SS
Sector
Location
Market Cap
USD 52.99 B
Share Price
USD 7.93
Avg Daily Volume
45,260,884
Change (1 day)
-1.14%
Change (1 year)
41.89%
Change (YTD)
26.22%
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 1.02 B
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow is USD 1.02 B for the year ending December 31, 2024, a -5.57% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 1.08 B, a 487.19% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 183.35 M, a -72.39% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 663.96 M, a 26.28% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 525.77 M, a -4.07% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Alnylam Pharmaceuticals, Inc.
USD 314.94
ALNY
-7.70
-2.39%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
MERCK Kommanditgesellschaft auf Aktien
USD 131.84
MRK.DE
-2.06
-1.54%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Alnylam Pharmaceuticals, Inc.
USD 314.94
ALNY
-7.70
-2.39%